Here, we provide a standardized and validated protocol for anti-FGFR3 antibody detection, and offer a method for antibody confirmation, thus paving the way for more accurate testing and multicenter investigations to understand the clinical relevance of anti-FGFR3 antibodies in sensory neuropathies. This evidence concerns the gene FGFR3 and sensory peripheral neuropathy.